Fibrillation, Atrial Clinical Trial
Official title:
Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)
The presence of interatrial block (IAB) is associated with the development of atrial fibrillation (AF). The aim of this study was to determine whether P-wave duration and presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.
Status | Completed |
Enrollment | 380 |
Est. completion date | December 31, 2016 |
Est. primary completion date | December 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - Patients in sinus rhythm - with or without previous paroxysmal AF - with dual-chamber pacemakers (PMs), implantable cardioverterdefibrillators (ICDs), and devices for cardiac resynchronization therapy (CRT) - capable of atrial activity monitoring were included in the study Exclusion Criteria: -Previous documented atrial fibrillation |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Atrial high rate new episodes | New episodes of atrial high rate episodes | 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00244725 -
Odiparcil For The Prevention Of Venous Thromboembolism
|
Phase 2 | |
Terminated |
NCT00437242 -
Odiparcil QT Definitive Study
|
Phase 1 | |
Completed |
NCT00402363 -
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
|
Phase 3 | |
Completed |
NCT00240643 -
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
|
Phase 2 | |
Completed |
NCT00041496 -
Prevention Of Recurrence Of Atrial Fibrillation
|
Phase 2 | |
Not yet recruiting |
NCT06200311 -
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
|
N/A | |
Withdrawn |
NCT03401931 -
Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers
|
||
Completed |
NCT04537507 -
Atrial Fibrillation and Non-obstructive Coronary Lesions
|
||
Completed |
NCT00911300 -
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
|
Phase 2 |